Daniel Chastain Profile
Daniel Chastain

@DBChastain

Followers
260
Following
599
Media
12
Statuses
240

Infectious diseases pharmacist | Clinical Associate Professor, UGA College of Pharmacy

Joined November 2020
Don't wanna be here? Send us removal request.
@DBChastain
Daniel Chastain
2 months
RT @drtimothyli: Suggested investigation of suspected immunosuppression*. *Also: recurrent deep abscesses, chronic diarrhoea with weight lo….
0
36
0
@DBChastain
Daniel Chastain
4 months
Thankful to have worked with @andhen25 and @GRThompsonMD in highlighting the low rates and inconsistent prescribing of PJP prophylaxis for patients on glucocorticoids ≥2 weeks in @CIDJournal.
@CIDJournal
Clinical Infectious Diseases
4 months
Glucocorticoids, Concomitant Immunosuppression, and PJP Prophylaxis Among U.S. Adults. ✅ Just Accepted.✍️ @DBChastain.🔗
Tweet media one
0
3
6
@DBChastain
Daniel Chastain
5 months
RT @BBookstaver_USC: The @AJHPOfficial ID themed issue was just released and we're (@stoverkr & I) excited to slowly share a brief synopsis….
0
8
0
@DBChastain
Daniel Chastain
5 months
RT @BBookstaver_USC: Thanks @ASP_PharmD .Here's a direct link to the ID themed issue:. I'll try and provide a brie….
0
4
0
@DBChastain
Daniel Chastain
6 months
Great collab w/ @UGAPharmacy students Meg George & Tonisha Gaitor, @andhen25, and @DavidCluck2, examining climate change's impact on fungal infections, incl. increased virulence, resistance, & emerging pathogens! Thanks @TAInfDis!
Tweet card summary image
journals.sagepub.com
Anthropogenic climate change, primarily driven by greenhouse gas emissions, is reshaping ecosystems and creating conditions that affect 58% of all known human i...
@TAInfDis
Therapeutic Advances in Infectious Disease
6 months
🌍🔥 Climate change is fueling the rise of fungal infections! Warmer temps, extreme weather & shifting ecosystems are making fungi more virulent & drug-resistant. With rising host susceptibility, the threat is growing.
0
1
3
@DBChastain
Daniel Chastain
8 months
RT @blandman19: Good discussion on pros and cons of potentially shortening treatment duration for candidemia by @UGAPharmacy faculty @DBCha….
0
3
0
@DBChastain
Daniel Chastain
8 months
RT @andhen25: Inspired on our recent trips to Peru and Zimbabwe . We have so much to learn from our Global South colleagues . #GlobalHealth….
0
3
0
@DBChastain
Daniel Chastain
9 months
RT @stoverkr: Looking for a PGY2 ID residency (or CC, or Peds)? Come see @UMMCPharmacy at either the SNPhA x ACCP showcase this week or at….
0
2
0
@DBChastain
Daniel Chastain
9 months
RT @andhen25: My beloved Cali, Colombia is hosting the 16th meeting of the Conference of the Parties to the Convention on Biological Divers….
0
5
0
@DBChastain
Daniel Chastain
9 months
Thanks, @hallpharms! It was a lot of fun putting these slides together and highlighting all the fantastic work being done with SAB.
0
0
6
@DBChastain
Daniel Chastain
9 months
What a fantastic session with @andhen25 and @bryan_p_white! Appreciate @IDWeekmtg for the opportunity to watch virtually.
@TAInfDis
Therapeutic Advances in Infectious Disease
9 months
So excited to hear from our super ⭐️ Editor in Chief @andhen25 about optimal therapy for invasive Candidiasis 🍄 #IDWeek2024
Tweet media one
0
0
9
@DBChastain
Daniel Chastain
9 months
Thank you so much @patricia_rdz_z! Appreciate you sharing the presentation.
@patricia_rdz_z
Patricia Rodriguez Zulueta
10 months
#IDWeek2024 Biterapia en bacteriemia por Estafilococo aureus, en Camera 1 y Camera 2 origen endovascular está subrepresentado .8-39% no responden a monoterapia. En quien considerarla riesgo de Bacteremia persistente estratificar pacientes . Great talk @DBChastain
Tweet media one
Tweet media two
0
0
2
@DBChastain
Daniel Chastain
9 months
You're the best @stoverkr! Thank you so much for all your support!.
@stoverkr
Kayla Stover
10 months
Kudos to #IDWeek2024 for providing the hybrid meeting option so I could watch this 🔥🔥 session with @DBChastain and moderated by @blandman19 on the way home.
Tweet media one
0
0
8
@DBChastain
Daniel Chastain
9 months
Well done, @ferraz_md! Congratulations!.
@andhen25
Andrés Henao, MD, PhD
9 months
A huge shoutout to the talented @ferraz_md for her inspiring poster and research on candidemia mortality differences by species at @IDWeekmtg 🌟 . Your work is crucial in advancing our understanding and treatment of this serious infection. Bravo! 👏🦠 . @CUDivofID @CUAnschutz
Tweet media one
0
1
11
@DBChastain
Daniel Chastain
9 months
RT @CalderwoodMD: I love these two slides on the evidence for combination therapy in persistent MRSA and MSSA bacteremia. References in foo….
0
149
0
@DBChastain
Daniel Chastain
9 months
Very grateful to @SAIRABT for sharing my slides from @IDWeekmtg. Exciting to see the presentation reaching a broader audience!.
@SAIRABT
Saira Butt
10 months
0
0
2
@DBChastain
Daniel Chastain
9 months
Thanks @CalderwoodMD for sharing my slides on this important @CIDJournal paper highlighting the diversity and longitudinal trends of SAB, with subphenotypes that impact outcomes—crucial insights for personalizing therapy.
@CalderwoodMD
Michael Calderwood, MD, MPH
10 months
Fascinating study discussed at #IDWeek2024. Four different clinical phenotypes for S aureus bacteremia. Highest mortality in A, lower mortality in B and E, microbiologic outcomes worse in C (with adjunctive rifampicin benefit seen in C).
Tweet media one
Tweet media two
Tweet media three
1
1
11
@DBChastain
Daniel Chastain
9 months
RT @andhen25: @DBChastain presenting adjunctive therapies for SAB @IDWeekmtg . Understanding different sub-phenotypes within MSSA and uniqu….
0
2
0